Ronald Dollens recently retired from the position of CEO and President of Guidant Corp, Indianapolis-based medical technology manufacturer. Dollens was appointed CEO and President of Guidant, the company was set up as a split-off of Eli Lilly and Co. in 1994. During the 10 years of his leadership at Guidant, the company has grown on average by 18% a year, from just under $ 900 million in sales in 1994 to $ 3.7 billion in 2003. Today, Guidant employs more than 12,000 and is a leader in the field of cardiovascular technology. "Hide
by Catherine M. Dalton Source: Business Horizons 11 pages. Publication Date: March 15, 2005. Prod. #: BH115-PDF-ENG
Related Case Solutions & Analyses:
Sustainability Challenges in the Shrimp Industry (B): Policy Alternatives
Note on Energy
Sara Campbell (B)
By Air or By Sea
International Paper: The Aussedat-Rey Acquisition
Ecolab Inc. (B)
Morningstar Inc.
Ratios Tell Story–2007
Buying Property in a Hot Market: NYC Creates a Fund to Keep Affordable Housing Developers in Play
Diamond Foods Inc.
